The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway
Open accessAbstract
Viruses must overcome diverse intracellular defense mechanisms to establish infection. The Vif (virion infectivity factor) protein of human immunodeficiency virus 1 (HIV-1) acts by overcoming the antiviral activity of APOBEC3G (CEM15), a cytidine deaminase that induces G to A hypermutation in newly synthesized viral DNA. In the absence of Vif, APOBEC3G incorporation into virions renders HIV-1 non-infectious. We report here that Vif counteracts the antiviral activity of APOBEC3G by targeting it for destruction by the ubiquitin-proteasome pathway. Vif forms a complex with APOBEC3G and enhances APOBEC3G ubiquitination, resulting in reduced steady-state APOBEC3G levels and a decrease in protein half-life. Furthermore, Vif-dependent degradation of APOBEC3G is blocked by proteasome inhibitors or ubiquitin mutant K48R. A mutation of highly conserved cysteines or the deletion of a conserved SLQ(Y/F)LA motif in Vif results in mutants that fail to induce APOBEC3G degradation and produce non-infectious HIV-1; however, mutations of conserved phosphorylation sites in Vif that impair viral replication do not affect APOBEC3G degradation, suggesting that Vif is important for other functions in addition to inducing proteasomal degradation of APOBEC3G. Vif is monoubiquitinated in the absence of APOBEC3G but is polyubiquitinated and rapidly degraded when APOBEC3G is coexpressed, suggesting that coexpression accelerates the degradation of both proteins. These results suggest that Vif functions by targeting APOBEC3G for degradation via the ubiquitin-proteasome pathway and implicate the proteasome as a site of dynamic interplay between microbial and cellular defenses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
Degradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Protein regulation by monoubiquitin
Hicke, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056583 · Cited by 1,211
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
Self-citationThe antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
Cited by
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
Intrinsic immunity: a front-line defense against viral attack
Bieniasz, P. D. (2004) · Nature Immunology · doi:10.1038/ni1125 · Cited by 454
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons
Chen, H., Lilley, C. E., Yu, Q., Lee, D. V., Chou, J., Narvaiza, I., Landau, N. R., & Weitzman, M. D. (2006) · Current Biology · doi:10.1016/j.cub.2006.01.031 · Cited by 389
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection
Jäger, S., Kim, D. Y., Hultquist, J. F., Shindo, K., LaRue, R. S., Kwon, E., Li, M., Anderson, B. D., Yen, L., Stanley, D., et al. (2012) · Nature · doi:10.1038/nature10693 · Cited by 352
HIV-1 Vif, APOBEC, and Intrinsic Immunity
Goila-Gaur, R., & Strebel, K. (2008) · Retrovirology · doi:10.1186/1742-4690-5-51 · Cited by 342
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Koning, F. A., Newman, E. N. C., Kim, E.-Y., Kunstman, K. J., Wolinsky, S. M., & Malim, M. H. (2009) · Journal of Virology · doi:10.1128/jvi.01089-09 · Cited by 336
Holmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607298200 · Cited by 308
Complementary function of the two catalytic domains of APOBEC3G
Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., & Landau, N. R. (2005) · Virology · doi:10.1016/j.virol.2005.01.011 · Cited by 305
Yu, Y., Xiao, Z., Ehrlich, E. S., Yu, X., & Yu, X.-F. (2004) · Genes & Development · doi:10.1101/gad.1250204 · Cited by 302
Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M., & Gabuzda, D. (2004) · Genes & Development · doi:10.1101/gad.1249904 · Cited by 296
Self-citationBogerd, H. P., Doehle, B. P., Wiegand, H. L., & Cullen, B. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307713101 · Cited by 295
APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication
Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D., & Landau, N. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408802200 · Cited by 293
Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors
Cullen, B. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1067-1076.2006 · Cited by 284
APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles
Zennou, V., Perez-Caballero, D., Göttlinger, H., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12058-12061.2004 · Cited by 281
APOBEC proteins and intrinsic resistance to HIV-1 infection
Malim, M. H. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0185 · Cited by 280
Gallois-Montbrun, S., Kramer, B., Swanson, C. M., Byers, H., Lynham, S., Ward, M., & Malim, M. H. (2007) · Journal of Virology · doi:10.1128/jvi.02287-06 · Cited by 279
Mbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. L., Mansky, L. M., Gorelick, R. J., Harris, R. S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00272-07 · Cited by 274
Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W.-S., & Pathak, V. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405761200 · Cited by 268
T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction
Zhang, W., Du, J., Evans, S. L., Yu, Y., & Yu, X.-F. (2012) · Nature · doi:10.1038/nature10718 · Cited by 264
APOBEC Enzymes as Targets for Virus and Cancer Therapy
Olson, M. E., Harris, R. S., & Harki, D. A. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.10.007 · Cited by 164
HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system
DeHart, J. L., Zimmerman, E. S., Ardon, O., Monteiro-Filho, C. M., Argañaraz, E. R., & Planelles, V. (2007) · Virology Journal · doi:10.1186/1743-422x-4-57 · Cited by 152
Ratcliff, J., & Simmonds, P. (2021) · Virology · doi:10.1016/j.virol.2020.12.018 · Cited by 108
Role of viral regulatory and accessory proteins in HIV-1 replication
Seelamgari, A. (2004) · Frontiers in Bioscience · doi:10.2741/1403 · Cited by 98
“(273) observed that Vif was modified by ubiquitination suggesting another possible route that may influence the function of Vif.”
BackgroundMultifaceted antiviral actions of APOBEC3 cytidine deaminases
Chiu, Y.-L., & Greene, W. C. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.003 · Cited by 72
Metadata
- Authors
- Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., & Gabuzda, D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 279
- Issue
- 9
- Pages
- 7792-7798
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2149138273
- Cited by
- 474
- References
- 35
- FWCI
- 14.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.